Peptídeos

A synthetic peptide for use as a blocking control in assays to test for specificity of ESRRG antibody, catalog no. 70R-1940

A synthetic peptide for use as a blocking control in assays to test for specificity of PRELP antibody, catalog no. 70R-5343

A synthetic peptide for use as a blocking control in assays to test for specificity of IDS antibody, catalog no. 70R-10208

A synthetic peptide for use as a blocking control in assays to test for specificity of TSR1 antibody, catalog no. 70R-3165

A synthetic peptide for use as a blocking control in assays to test for specificity of UTY antibody, catalog no. 70R-6950

A synthetic peptide for use as a blocking control in assays to test for specificity of TUBB6 antibody, catalog no. 70R-10057

A synthetic peptide for use as a blocking control in assays to test for specificity of R3HDM2 antibody, catalog no. 70R-4232

A synthetic peptide for use as a blocking control in assays to test for specificity of IGLL1 antibody, catalog no. 70R-1641

A synthetic peptide for use as a blocking control in assays to test for specificity of LIPF antibody, catalog no. 70R-5368

A synthetic peptide for use as a blocking control in assays to test for specificity of TASP1 antibody, catalog no. 70R-4354

A synthetic peptide for use as a blocking control in assays to test for specificity of PPME1 antibody, catalog no. 70R-3708

A synthetic peptide for use as a blocking control in assays to test for specificity of UCHL3 antibody, catalog no. 70R-3126

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC20A2 antibody, catalog no. 70R-7534

A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ14803 antibody, catalog no. 70R-6988

A synthetic peptide for use as a blocking control in assays to test for specificity of B4GALT2 antibody, catalog no. 70R-6780

A synthetic peptide for use as a blocking control in assays to test for specificity of CACNB2 antibody, catalog no. 70R-5066

A synthetic peptide for use as a blocking control in assays to test for specificity of LGALS9 antibody, catalog no. 70R-5743

Anti ACTH (1-23) (Rat) Serum is a recombinant peptide that is an activator of the hypothalamus. It has been shown to have a high affinity for the receptor, and it can be used as a research tool in cell biology and pharmacology. Anti ACTH (1-23) (Rat) Serum is used in the study of ion channels, ligands, and antibodies. This peptide has been used to inhibit the release of ACTH from the pituitary gland and can be used to study the effects of anti-ACTH on other hormones. Anti ACTH (1-23) (Rat) Serum is purified from E. coli cells with a CAS number of 58612-37-8.

A synthetic peptide for use as a blocking control in assays to test for specificity of LCN12 antibody, catalog no. 70R-5485

Thrombin Receptor Activator Peptide 6 (TRAP-6), also called Selective Protease-Activated Receptor 1 (PAR-1) Agonist, is an hexapeptide fragment of the thrombin receptor (residues 42-47).

A synthetic peptide for use as a blocking control in assays to test for specificity of RAD54B antibody, catalog no. 70R-5652

A synthetic peptide for use as a blocking control in assays to test for specificity of PRR5 antibody, catalog no. 70R-9436

A synthetic peptide for use as a blocking control in assays to test for specificity of ART3 antibody, catalog no. 70R-6841

A synthetic peptide for use as a blocking control in assays to test for specificity of LUC7L antibody, catalog no. 70R-9549

A synthetic peptide for use as a blocking control in assays to test for specificity of IFLTD1 antibody, catalog no. 70R-4170

A synthetic peptide for use as a blocking control in assays to test for specificity of CD8B antibody, catalog no. 70R-5988

A synthetic peptide for use as a blocking control in assays to test for specificity of SRrp35 antibody, catalog no. 70R-4839

A synthetic peptide for use as a blocking control in assays to test for specificity of OSTF1 antibody, catalog no. 70R-10362

A synthetic peptide for use as a blocking control in assays to test for specificity of FLJ37543 antibody, catalog no. 70R-3454

A synthetic peptide for use as a blocking control in assays to test for specificity of Gtf2b antibody, catalog no. 70R-9577

Cytochrome B5 Reductase 3, human, recombinant is a high-quality protein used in research and scientific studies. Produced using Escherichia Coli, this protein is essential for various biological processes. Cytochrome B5 Reductase 3 plays a crucial role in electron transfer reactions and is involved in the metabolism of drugs and toxins. It has been extensively studied for its ability to catalyze the reduction of cytochrome b5, an important component of the electron transport chain. This recombinant protein provides researchers with a reliable tool to investigate cellular processes and advance scientific knowledge.

A synthetic peptide for use as a blocking control in assays to test for specificity of PDZK1 antibody, catalog no. 70R-3097

A synthetic peptide for use as a blocking control in assays to test for specificity of GBA antibody, catalog no. 70R-10294

A synthetic peptide for use as a blocking control in assays to test for specificity of MYBPH antibody, catalog no. 70R-6049

A synthetic peptide for use as a blocking control in assays to test for specificity of C1QB antibody, catalog no. 70R-5990

Autoinducing peptide (AIPs) are produced by Staphylococcus aureus bacterium in order to regulate virulence.

HG1 toxin is a peptide that is found in the venom of the scorpion Heterometrus fulvipes. It is a member of the short-chain scorpion toxins, which are composed of a single chain of amino acids. This protein has been shown to bind to potassium channels and inhibit their function, leading to paralysis of the prey's nervous system. HG1 toxin has been shown to be able to activate or inhibit ion channels and other receptors. It can also bind to ligands such as peptides or antibodies and affect cellular activity. HG1 toxin is produced by recombinant DNA technology and purified by HPLC for use in biochemical research and pharmacological studies.

A synthetic peptide for use as a blocking control in assays to test for specificity of LOXL1 antibody, catalog no. 70R-5312

A synthetic peptide for use as a blocking control in assays to test for specificity of C16orf48 antibody, catalog no. 70R-4110

A synthetic peptide for use as a blocking control in assays to test for specificity of MAPK6 antibody, catalog no. 70R-9395

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF251 antibody, catalog no. 70R-8176

A synthetic peptide for use as a blocking control in assays to test for specificity of CPA6 antibody, catalog no. 70R-9497

A synthetic peptide for use as a blocking control in assays to test for specificity of ACP1 antibody, catalog no. 70R-1276

A synthetic peptide for use as a blocking control in assays to test for specificity of PSMB2 antibody, catalog no. 70R-2346

CTGF Human is a research tool that is used to investigate how CTGF interacts with its receptor and other proteins. The CTGF protein can bind to the Cell Biology, Antibodies, Ion Channels, Pharmacology, Peptides, and Life Science fields. It is an inhibitor for Lipases.

A synthetic peptide for use as a blocking control in assays to test for specificity of GPCR5A antibody, catalog no. 70R-6472

A synthetic peptide for use as a blocking control in assays to test for specificity of RNF217 antibody, catalog no. 70R-6685

A synthetic peptide for use as a blocking control in assays to test for specificity of BHMT antibody, catalog no. 70R-1220

A synthetic peptide for use as a blocking control in assays to test for specificity of TBC1D24 antibody, catalog no. 70R-4064

A synthetic peptide for use as a blocking control in assays to test for specificity of SLCO3A1 antibody, catalog no. 70R-6586

A TIMP1 Heavy Tryptic Peptide Standard for protein identification and quantitation studies. TIMP1, also known as TIMP metallopeptidase inhibitor 1 is an inhibitor of matrix metalloproteinases, which are enzymes that break down the extracellular matrix. It has also been associated with cell proliferation promotion and may have a role in apoptosis.

Bradykinin is a peptide that is generated by the breakdown of kininogen, a protein found in the blood. Bradykinin is an important mediator of inflammation and vasodilation. It also has many other functions, such as the regulation of tissue fluid homeostasis, pain perception, and the release of hormones from endocrine glands. The human form of bradykinin is derived from the precursor molecule kininogen through proteolytic cleavage by kallikrein or kallidin and subsequent conversion to bradykinin by either carboxypeptidases A or B. The bovine form arises from proteolysis at Arg-Arg-Lys-Arg sites whereas rat bradykinin arises from Arg-Lys sites in kininogen. Mouse bradykinin arises primarily from Arg-Arg sites in kininogen.

A synthetic peptide for use as a blocking control in assays to test for specificity of LRRN3 antibody, catalog no. 70R-6404

A synthetic peptide for use as a blocking control in assays to test for specificity of GABRB2 antibody, catalog no. 70R-1531

A synthetic peptide for use as a blocking control in assays to test for specificity of GJC1 antibody, catalog no. 70R-6189

CD2, human, recombinant is a research peptide that is commonly used in scientific studies. It is a protein that is produced using Escherichia Coli bacteria. CD2 plays an important role in immune responses and cell signaling. This recombinant form of CD2 allows researchers to study its function and interactions with other molecules in a controlled laboratory setting. It can be used in various experiments and assays to investigate the mechanisms of immune system regulation and develop potential therapeutic interventions. With its high purity and quality, CD2, human, recombinant is a valuable tool for researchers in the field of immunology and molecular biology.

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF597 antibody, catalog no. 70R-8426

MAGE-A3 (112-120) peptide – KVAELVHFL – Epitope of Melanoma Antigen Gene A3

A synthetic peptide for use as a blocking control in assays to test for specificity of C3orf18 antibody, catalog no. 70R-6877

A synthetic peptide for use as a blocking control in assays to test for specificity of C9orf95 antibody, catalog no. 70R-9471

A synthetic peptide for use as a blocking control in assays to test for specificity of COMT antibody, catalog no. 70R-7143

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC35A5 antibody, catalog no. 70R-7166

A synthetic peptide for use as a blocking control in assays to test for specificity of KIAA0427 antibody, catalog no. 70R-4855

A synthetic peptide for use as a blocking control in assays to test for specificity of NECAB3 antibody, catalog no. 70R-3495

A synthetic peptide for use as a blocking control in assays to test for specificity of ANKRD27 antibody, catalog no. 70R-10062

A synthetic peptide for use as a blocking control in assays to test for specificity of F7 antibody, catalog no. 70R-9970

IL-9 is a cytokine that is involved in the regulation of immune system. IL-9 signaling is essential for the induction of B cell responses and mast cell activation, and IL-9 is also expressed in epithelial cells. The IL-9 Mouse (CAS No. 207870-05-2) antibody reacts with IL-9 protein, which has a molecular weight of 18 kDa. This antibody detects an epitope corresponding to amino acids 1 to 13 of human Interleukin 9 (IL-9).

A synthetic peptide for use as a blocking control in assays to test for specificity of KCNK10 antibody, catalog no. 70R-5210

α7 nAChR selective blocker

Omega-Conotoxin MVIIA is a neurotoxin that inhibits voltage-dependent calcium channels and has been shown to be effective against neuropathic pain, chronic pain, and inflammatory pain. The long-term efficacy of this drug is due to its ability to block cytosolic calcium, which leads to the activation of neurotrophic factors. Omega-Conotoxin MVIIA binds to specific protein targets and inhibits ion channel activity in neurons. This toxin can also inhibit the production of proinflammatory cytokines by blocking the activation of NF-κB through intracellular targets. Omega-Conotoxin MVIIA has been shown to have a wide range of therapeutic potentials, including as an analgesic for acute and chronic pain, as an anti-inflammatory agent, and as a neuroprotective agent for treating neuronal degeneration.

A synthetic peptide for use as a blocking control in assays to test for specificity of PQLC1 antibody, catalog no. 70R-7332

A synthetic peptide for use as a blocking control in assays to test for specificity of CSN3 antibody, catalog no. 70R-9142

A synthetic peptide for use as a blocking control in assays to test for specificity of OR6C68 antibody, catalog no. 70R-6774

H-Thr-Glu-OH is a nucleotide that is a component of RNA. It is one of the 20 natural amino acids and it is found in proteins as well as in RNA molecules. H-Thr-Glu-OH can be synthesized by hydrolysis of proteins with an enzyme called glutamic acid hydrolase. H-Thr-Glu-OH has been shown to have a high affinity for lysine, which has been shown to be required for the enzymatic activity of many protein enzymes. This amino acid can also be found in large quantities in cheese, soy sauce, and yogurt.

A synthetic peptide for use as a blocking control in assays to test for specificity of VTI1A antibody, catalog no. 70R-6971

The 6-Fluoro-3-indoxyl-beta-D-galactopyranoside is a powerful antituberculosis drug that falls under the class of rifamycins. It is highly effective in treating tuberculosis infections due to its bactericidal activity. This compound works by inhibiting bacterial growth through binding to DNA-dependent RNA polymerase, thereby preventing transcription and replication. Its potency has been demonstrated through extensive research using the patch-clamp technique on human erythrocytes. Furthermore, this active compound undergoes various metabolic transformations, including hydrolysis by esterases or glucuronidases, oxidation by cytochrome P450 enzymes, reduction by glutathione reductase, or conjugation with glucuronic acid. Additionally, it specifically targets markers expressed at high levels in Mycobacterium tuberculosis strains, inhibiting their cell growth in culture.

A synthetic peptide for use as a blocking control in assays to test for specificity of PLXNA2 antibody, catalog no. 70R-6314

A synthetic peptide for use as a blocking control in assays to test for specificity of LOXL1 antibody, catalog no. 70R-5381

A synthetic peptide for use as a blocking control in assays to test for specificity of RBMS3 antibody, catalog no. 70R-1318

A synthetic peptide for use as a blocking control in assays to test for specificity of Dyrk1a antibody, catalog no. 70R-8634

A synthetic peptide for use as a blocking control in assays to test for specificity of CRMP1 antibody, catalog no. 70R-5249

CD20 (188-196) is a short part of a membrane phosphoprotein, CD20, which is expressed on the surface of B cells. CD20 receptor is an important target for immunotherapy against B cell lymphoma. CD20 epitopes are used in antibodies CD20 production, such as the production of the first monoclonal antibody to be approved for the treatment of lymphoma.
Applications of CD20 (188-196):
CD20 (188-196) is involved in research to generate cytotoxic T lymphocytes and stimulate CTL responses against B cell diseases. The production of specific T cells and IFN-γ are quantified by ELISPOT. CD20 (188-196) has been identified as a highly immunogenic HLA-A2 restricted peptide. Results suggest that CD20 (188-196) may serve in immunotherapeutic strategies especially for vaccine development against certain type of blood cancer.
CD20 (188-196) is also used in research on cell therapy as target for T cell receptor. In fact, T cells are modified in vivo to express specific T cell receptor and then inject modified cells in B cells cancer patient in order to recognized malignant B cells and treat them.

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC13A2 antibody, catalog no. 70R-7364

A synthetic peptide for use as a blocking control in assays to test for specificity of ASNA1 antibody, catalog no. 70R-10011

A synthetic peptide for use as a blocking control in assays to test for specificity of KCTD15 antibody, catalog no. 70R-5046

A synthetic peptide for use as a blocking control in assays to test for specificity of HSD17B14 antibody, catalog no. 70R-4347

A synthetic peptide for use as a blocking control in assays to test for specificity of PDIA4 antibody, catalog no. 70R-7388

A synthetic peptide for use as a blocking control in assays to test for specificity of GABRB1 antibody, catalog no. 20R-1330

A synthetic peptide for use as a blocking control in assays to test for specificity of SLC4A2 antibody, catalog no. 70R-6773

Portion of Influenza A

A synthetic peptide for use as a blocking control in assays to test for specificity of DBT antibody, catalog no. 70R-2499

A synthetic peptide for use as a blocking control in assays to test for specificity of SNAPC1 antibody, catalog no. 20R-1196

A synthetic peptide for use as a blocking control in assays to test for specificity of TRIT1 antibody, catalog no. 70R-8332

A synthetic peptide for use as a blocking control in assays to test for specificity of ZADH2 antibody, catalog no. 70R-4445

A synthetic peptide for use as a blocking control in assays to test for specificity of ADAD2 antibody, catalog no. 70R-4837

A synthetic peptide for use as a blocking control in assays to test for specificity of ZNF205 antibody, catalog no. 70R-8254

A synthetic peptide for use as a blocking control in assays to test for specificity of TMEM166 antibody, catalog no. 70R-6649

A synthetic peptide for use as a blocking control in assays to test for specificity of HGF antibody, catalog no. 70R-5700